{"id":14276,"date":"2022-11-15T10:17:00","date_gmt":"2022-11-15T15:17:00","guid":{"rendered":"https:\/\/18fbf770e8.nxcli.io\/?post_type=whitepapers&#038;p=14276"},"modified":"2022-12-08T09:10:43","modified_gmt":"2022-12-08T14:10:43","slug":"walmart-potwierdza-3b-deal-ponad-apteki-sprzedaz-opioidow","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/pl\/biale-papiery\/walmart-potwierdza-3b-deal-ponad-apteki-sprzedaz-opioidow\/","title":{"rendered":"Walmart potwierdza umow\u0119 $3B dotycz\u0105c\u0105 sprzeda\u017cy opioid\u00f3w przez apteki"},"content":{"rendered":"<p>Walmart officially revealed a $3.1 billion offer Tuesday that ended thousands of lawsuits accusing its nationwide pharmacy network of fueling America&#8217;s deadly crisis of opioid abuse, echoing similar settlements involving CBS Pharmacy and Walgreens.<\/p>\n\n\n\n<p>The 10-figure proposal from Walmart Inc. &#8211; the world&#8217;s largest corporation and America&#8217;s third-largest pharmacy business &#8211; seeks to extinguish more than 2,000 lawsuits brought by cities, counties, states, and Native American tribes, as well as the potential legal claims of government entities that haven&#8217;t yet sued.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.law360.com\/classaction\/articles\/1549292\/walmart-confirms-3b-deal-over-pharmacies-opioid-sales\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Oryginalny artyku\u0142 znajdziesz tutaj<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Walmart oficjalnie ujawni\u0142 we wtorek ofert\u0119 o warto\u015bci $3,1 miliarda, kt\u00f3ra zako\u0144czy\u0142a tysi\u0105ce proces\u00f3w s\u0105dowych oskar\u017caj\u0105cych og\u00f3lnokrajow\u0105 sie\u0107 aptek o podsycanie \u015bmiertelnego kryzysu w Ameryce zwi\u0105zanego z nadu\u017cywaniem opioid\u00f3w, powtarzaj\u0105c podobne ugody dotycz\u0105ce\u2026<\/p>","protected":false},"featured_media":0,"menu_order":19,"template":"","whitepaper_category":[253,254,75],"whitepaper-source":[],"class_list":["post-14276","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper_category-opioids-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/14276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/14276\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/media?parent=14276"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper_category?post=14276"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper-source?post=14276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}